Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Singleton

Showing results (191-200 of 286) with videos related to

Pageof 29
Sort By:
American Journal of Human Genetics|November 20, 2010
Genome-wide screen identifies rs646776 near sortilin as a regulator of progranulin levels in human plasmaMinerva M Carrasquillo, Alexandra M Nicholson, NiCole Finch, et al.
The New England Journal of Medicine|November 16, 2012
TREM2 variants in Alzheimer's diseaseRita Guerreiro, Aleksandra Wojtas, Jose Bras, et al.
The Lancet. Neurology|October 21, 2006
Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of dataHon-Chung Fung, Sonja Scholz, Mar Matarin, et al.
NPJ Parkinson'S Disease|September 13, 2023
Author Correction: Elucidating causative gene variants in hereditary Parkinson's disease in the Global Parkinson's Genetics Program (GP2)Lara M Lange, Micol Avenali, Melina Ellis, et al.
American Journal of Human Genetics|October 23, 2008
Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymesXin Yuan, Dawn Waterworth, John R B Perry, et al.
Plos One|May 19, 2017
Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson diseaseChelsea Caspell-Garcia, Tanya Simuni, Duygu Tosun-Turgut, et al.
NPJ Parkinson'S Disease|June 27, 2023
Elucidating causative gene variants in hereditary Parkinson's disease in the Global Parkinson's Genetics Program (GP2)Lara M Lange, Micol Avenali, Melina Ellis, et al.
Frontiers in Neurology|August 28, 2020
Genetic and Phenotypic Basis of Autosomal Dominant Parkinson's Disease in a Large Multi-Center CohortSuzanne Lesage, Marion Houot, Graziella Mangone, et al.
Medrxiv : the Preprint Server for Health Sciences|April 29, 2026
Bridging Genetics and Precision Medicine in Parkinson's Disease through GP2Kajsa Atterling Brolin, Lara M Lange, Emily Navarro-Jones, et al.
The Lancet. Neurology|November 4, 2019
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional studyTanya Simuni, Liz Uribe, Hyunkeun Ryan Cho, et al.
Pageof 29

Showing results (191-200 of 286) with videos related to

Sort By:
Pageof 29
American Journal of Human Genetics|November 20, 2010
Genome-wide screen identifies rs646776 near sortilin as a regulator of progranulin levels in human plasmaMinerva M Carrasquillo, Alexandra M Nicholson, NiCole Finch, et al.
The New England Journal of Medicine|November 16, 2012
TREM2 variants in Alzheimer's diseaseRita Guerreiro, Aleksandra Wojtas, Jose Bras, et al.
The Lancet. Neurology|October 21, 2006
Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of dataHon-Chung Fung, Sonja Scholz, Mar Matarin, et al.
NPJ Parkinson'S Disease|September 13, 2023
Author Correction: Elucidating causative gene variants in hereditary Parkinson's disease in the Global Parkinson's Genetics Program (GP2)Lara M Lange, Micol Avenali, Melina Ellis, et al.
American Journal of Human Genetics|October 23, 2008
Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymesXin Yuan, Dawn Waterworth, John R B Perry, et al.
Plos One|May 19, 2017
Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson diseaseChelsea Caspell-Garcia, Tanya Simuni, Duygu Tosun-Turgut, et al.
NPJ Parkinson'S Disease|June 27, 2023
Elucidating causative gene variants in hereditary Parkinson's disease in the Global Parkinson's Genetics Program (GP2)Lara M Lange, Micol Avenali, Melina Ellis, et al.
Frontiers in Neurology|August 28, 2020
Genetic and Phenotypic Basis of Autosomal Dominant Parkinson's Disease in a Large Multi-Center CohortSuzanne Lesage, Marion Houot, Graziella Mangone, et al.
Medrxiv : the Preprint Server for Health Sciences|April 29, 2026
Bridging Genetics and Precision Medicine in Parkinson's Disease through GP2Kajsa Atterling Brolin, Lara M Lange, Emily Navarro-Jones, et al.
The Lancet. Neurology|November 4, 2019
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional studyTanya Simuni, Liz Uribe, Hyunkeun Ryan Cho, et al.
Pageof 29